Vaccinations for Children aged 6 Months to 5 Years.

Following the Therapeutic Goods Administration’s (TGA) approval of the Spikvax (Moderna) vaccine for children aged 6mths to 5 years, the Australian Technical Advisory Group on Immunisation (ATAGI) has provided recommendations in on the use of Moderna in children aged 6mths to under 5 years in certain at risk populations groups.

3 August DoH Provider Bulletin is here

ATAGI Recommendations are here

Fourth  Vaccine Dose Eligibility

The Australian Technical Advisory Group on Immunisation (ATAGI) has updated its recommendations for an additional
booster dose (also known as a fourth dose) for selected population groups (below) who are at greatest risk of severe illness
from COVID-19 and who have received their primary vaccination course and first booster dose.

Prevention of severe illness from COVID-19 is now the primary goal of the ongoing COVID-19 vaccination program, with the
secondary aim of the COVID-19 vaccination program being the prevention of infection and transmission of the virus.

The ATAGI Fourth Dose Eligibility bulletin is here